Legislation & Regulation
Richard Mark Kirkner
Anna Sinaiko
Price transparency mandates are catching on. But they may codify that which hasn’t worked all that well so far.
Viewpoint
Craig Kasten
Health care is increasingly becoming like other retail encounters—a transaction between buyers and sellers. Patients, providers, payers—everybody needs to adjust. With the right technology and the will to change, the process of paying for health care can become as simple—and as painless—as getting a haircut.
News & Commentary
Antibiotic resistance increases the cost of treating a bacterial infection by $1,383 and adds $2.2 billion to the country’s health care spending. Inpatient care is the biggest contributor to the incremental cost. Also costs related to antibiotic resistance were higher for older people and those in poor health.
News Wire
Therapy approved for adults and children with refractory PMBCL or who have relapsed after two or more prior lines of therapy
FDA questioning the pharmacokinetics of psoriasis lotion Duobrii
Approval acquired through tropical disease priority review voucher program
Some experts still opposed to “right to try” treatments
However, patent dispute will delay one launch
Priced out of health care
Timothy Kelley
Even the most effective drug is useless if people don’t take it because it’s so expensive. Today’s high prices are pushing more and more patients into nonadherence. It’s a prescription for trouble for us all.
Too many Americans are skipping prescribed medications because they find them too expensive. That foretells trouble for payers—and for patients. On this page, you’ll find several relevant facts and numbers.
News & Commentary
Researchers used callers, posing as the uninsured, to call primary care offices. They got appointments if they could pay the fee. Things changed, however, if the callers tried to work out a deal by which they would pay in installments. Far fewer callers could get appointments in such cases.
Now available

Precision medicine, big data, Alzheimer’s Disease, migraine, and RNA therapeutics.
Learnings from the April 2018 meeting.
Edited by Jill Condello, PhD, ICON Access, Commercialisation & Communications

CURRENT ISSUE June 2018

Medicine Doesn’t Work If Patients Don’t Take It

And yet, nonadherence not only persists, but the costs of more effective medications makes the problem worse. As our cover story notes, nonadherence impairs and even shortens life, and that’s toxic for a health system that has trouble controlling costs as it is.

Mainly, though, this issue is about managing diabetes. Our story looks at how Nevadan lawmakers are pushing a bill that requires more transparency from drugmakers. As other states mull similar action, pharma companies push back.

We  also look at new guidelines from the American College of Physicians that recommend less-aggressive blood sugar targets. Other professional groups think that’s a terrible idea.

Meanwhile, researchers have proposed a new taxonomy that divides diabetes into clusters instead of types.

UPCOMING MEETINGS
Philadelphia, PA
July 16-17, 2018
Los Angeles, CA
July 16-17, 2018
Alexandria, VA
July 16-17, 2018
Alexandria, VA
July 16-17, 2018
San Diego, CA
July 23-24, 2018
Philadelphia, PA
July 23, 2018
News & Commentary
Frequent shift work, particularly at night, increases type 2 diabetes risk factors, according to a study in Diabetes Care. Researchers at Brigham and Women’s Hospital in Boston looked at the impact on 270,000 people who currently work the night shift, using data from the UK Biobank.
Robert Calandra
The industry has been criticized for lack of transparency—and worse. Some see ‘a ton of sense’ in the proposed mergers with insurers and retailers. Others see a risk of even higher drug prices and a need for oversight.
Jan Greene
Christine Lee, MD
SAID, MOD, MARD—Swedish researchers are proposing a new taxonomy for diabetes based on a cluster of factors.